Preclinical studies underscore their efficacy in reducing hyperglycemia, enhancing insulin sensitivity, preserving pancreatic β-cell function, and protecting against diabetic complications, including nephropathy and cardiovascular diseases. The gene discussed is INS; the disease is Hyperglycemia.